MRAI.OQXMarpai, INC

DEFR14A: Marpai, Inc. Seeks Stockholder Approval for Director Elections, Incentive Plan, Auditor Ratification, and Preferred Stock Authorization

Sentiment:

Proxy Statement


Marpai, Inc. is holding its annual meeting of stockholders on May 6, 2024, to vote on key proposals including the election of directors, adoption of a stock incentive plan, ratification of the company's auditor, and authorization of preferred stock.

Capital raiseThe proposal to authorize 2,000,000 shares of preferred stock suggests a potential future capital raise.The board believes that approval of this Charter Amendment Proposal will provide the flexibility to take advantage of opportunities as they arise and will improve the Company's ability to attract investment capital as various series of preferred stock may be customized to meet the needs of particular transactions or market conditions.

Summary

  • Marpai, Inc. is convening its annual stockholder meeting on May 6, 2024, to address several key proposals.
  • Stockholders will vote to elect eight directors for a one-year term.
  • A vote will be held to adopt the Marpai, Inc. Global Stock Incentive Plan (2024).
  • The appointment of UHY LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, will be ratified.
  • Stockholders will also consider a proposal to amend the company's Certificate of Incorporation to authorize 2,000,000 shares of preferred stock.
  • The board of directors recommends voting FOR all proposals.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting necessary information for the upcoming shareholder meeting. The proposals are standard corporate governance matters, with potential benefits and risks outlined.

Positives

  • The Global Stock Incentive Plan (2024) aims to align the interests of employees, directors, and consultants with those of the stockholders.
  • Authorizing preferred stock provides the company with flexibility to attract investment capital and take advantage of opportunities as they arise.
  • The board of directors is comprised of individuals with diverse experience in healthcare, technology, and finance.

Negatives

  • The authorization of preferred stock could potentially dilute the voting power or other rights of existing common stockholders.
  • The board has no definitive plans, proposals or arrangements to issue any shares of blank check preferred stock.

Risks

  • The availability of undesignated blank check preferred stock may have certain negative effects on the rights of holders of Common Stock.
  • The Board will be permitted, without future stockholder approval, to issue preferred stock with dividend, liquidation, conversion, or voting or other rights which are superior to and could adversely affect the voting power or other rights of the holders of Common Stock.
  • The blank check preferred stock could be used, under certain circumstances, as a method of discouraging, delaying or preventing a change in control of the Company.

Future Outlook

The Board believes that approval of the Charter Amendment Proposal will provide the flexibility to take advantage of opportunities as they arise and will improve the Company’s ability to attract investment capital as various series of preferred stock may be customized to meet the needs of particular transactions or market conditions.

Management Comments

  • The Board unanimously recommends that the stockholders vote FOR all proposals being put before our stockholders at the Meeting.

Stakeholder Impact

  • Approval of the proposals will impact shareholders through potential changes in voting rights, equity dilution, and the company's ability to raise capital.
  • Employees, directors, and consultants may be affected by the adoption of the Global Stock Incentive Plan (2024).

Next Steps

  • Stockholders are requested to vote on the proposals outlined in the proxy statement.
  • The Board will adopt a resolution setting forth the Amendment to the Second Amended and Restated Certificate, declare its advisability, and authorize its filing with the Secretary of State of the State of Delaware, that the Company will promptly file such Amendment to the Second Amended and Restated Certificate with the Secretary of State of the State of Delaware, and that such Amendment to the Second Amended and Restated Certificate will become effective upon such filing.

Key Dates

DateDescription
March 7, 2024Record date for the Annual Meeting
March 13, 2024Board adopted the 2024 Plan, subject to stockholder approval
March 13, 2024Audit Committee appointed UHY LLP as independent auditors
April 17, 2024Date of proxy statement
April 18, 2024Intended mailing date of proxy statement and accompanying proxy card
May 6, 2024Annual Meeting of Stockholders
December 31, 2024Fiscal year end for which UHY LLP is appointed as auditor

Keywords

stockholders, directors, incentive plan, preferred stock, auditor, Marpai

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.